Literature DB >> 23558718

[International guidelines of the Surviving Sepsis Campaign : update 2012].

J Briegel1, P Möhnle.   

Abstract

An update of the international guidelines for therapy of sepsis was published in February 2012 by the Surviving Sepsis Campaign (SSC). The update includes a further development of the guidelines from 2004 and 2008. The guidelines are divided into three sections, sepsis-specific therapeutic measures, recommendations on general intensive care measures for sepsis and finally special features of sepsis in pediatric intensive care medicine are presented in detail. This article discusses the most important amendments in the first two sections and delving deeper into the guidelines.

Entities:  

Mesh:

Year:  2013        PMID: 23558718     DOI: 10.1007/s00101-013-2158-x

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  36 in total

1.  Guidelines for the use of platelet transfusions.

Authors: 
Journal:  Br J Haematol       Date:  2003-07       Impact factor: 6.998

2.  Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly.

Authors:  Peter Q Eichacker; Charles Natanson; Robert L Danner
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

Review 3.  [The cost of sepsis].

Authors:  O Moerer; H Burchardi
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

Review 4.  [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients].

Authors:  M Hochreiter; S Schroeder
Journal:  Anaesthesist       Date:  2011-07       Impact factor: 1.041

5.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Authors:  B L Warren; A Eid; P Singer; S S Pillay; P Carl; I Novak; P Chalupa; A Atherstone; I Pénzes; A Kübler; S Knaub; H O Keinecke; H Heinrichs; F Schindel; M Juers; R C Bone; S M Opal
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

6.  Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial.

Authors:  Tim C Jansen; Jasper van Bommel; F Jeanette Schoonderbeek; Steven J Sleeswijk Visser; Johan M van der Klooster; Alex P Lima; Sten P Willemsen; Jan Bakker
Journal:  Am J Respir Crit Care Med       Date:  2010-05-12       Impact factor: 21.405

7.  Neuromuscular blockers in early acute respiratory distress syndrome.

Authors:  Laurent Papazian; Jean-Marie Forel; Arnaud Gacouin; Christine Penot-Ragon; Gilles Perrin; Anderson Loundou; Samir Jaber; Jean-Michel Arnal; Didier Perez; Jean-Marie Seghboyan; Jean-Michel Constantin; Pierre Courant; Jean-Yves Lefrant; Claude Guérin; Gwenaël Prat; Sophie Morange; Antoine Roch
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

8.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

9.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

10.  Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study.

Authors:  Xavier Forceville; Bruno Laviolle; Djillali Annane; Dominique Vitoux; Gérard Bleichner; Jean-Michel Korach; Emmanuel Cantais; Hugues Georges; Jean-Louis Soubirou; Alain Combes; Eric Bellissant
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  5 in total

Review 1.  Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis.

Authors:  Sigrid Beitland; Irene Sandven; Lill-Kristin Kjærvik; Per Morten Sandset; Kjetil Sunde; Torsten Eken
Journal:  Intensive Care Med       Date:  2015-05-14       Impact factor: 17.440

2.  [Impairment of oxygenation of patients in surgical intensive care : Early symptom of severe sepsis].

Authors:  M Hückstädt; G O Hofmann; T Mendel; R Stuttmann; P Hilbert-Carius
Journal:  Anaesthesist       Date:  2016-10-05       Impact factor: 1.041

3.  Ventilation management in acute respiratory failure related to COVID-19 versus ARDS from another origin - a descriptive narrative review.

Authors:  Anissa M Tsonas; Michela Botta; Ary Serpa Neto; Janneke Horn; Frederique Paulus; Marcus J Schultz
Journal:  Expert Rev Respir Med       Date:  2021-04-13       Impact factor: 3.772

Review 4.  Hydrogen gas presents a promising therapeutic strategy for sepsis.

Authors:  Keliang Xie; Lingling Liu; Yonghao Yu; Guolin Wang
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

5.  Procalcitonin as a prognostic marker for sepsis: a prospective observational study.

Authors:  Saransh Jain; Sanjeev Sinha; Surendra K Sharma; J C Samantaray; Praveen Aggrawal; Naval Kishore Vikram; Ashutosh Biswas; Seema Sood; Manish Goel; Madhuchhanda Das; Sreenivas Vishnubhatla; Nawaid Khan
Journal:  BMC Res Notes       Date:  2014-07-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.